首页> 外文期刊>Analytical chemistry >Comparison of Immunoreactivity of Staphylococcal Enterotoxin B Mutants for Use as Toxin Surrogates
【24h】

Comparison of Immunoreactivity of Staphylococcal Enterotoxin B Mutants for Use as Toxin Surrogates

机译:金黄色葡萄球菌肠毒素B突变体用作毒素替代物的免疫反应性比较

获取原文
获取原文并翻译 | 示例
       

摘要

The development and testing of detection methodologies for biothreat agents are by their very nature complicated by the necessity to handle hazardous materials. Toxoids prepared by thermal or chemical inactivation are often used in place of the native toxin; however, the process of detoxification can decrease the agent's ability to be detected at similar concentrations. One method to overcome this limitation is the use of toxin mutants which have altered amino acid sequences sufficient to abrogate or greatly reduce their toxic activity. While this method of toxoid preparation is much more controlled, there is still no guarantee that the resulting product will be equal in detectability to the native toxin. In this work, we have evaluated the utility of two recombinantly expressed Staphylococcal Enterotoxin B (SEB) mutants, a single point mutant (Y89A), and a mutant with three amino acids changed (L45R, Y89A, Y94A), to act as surrogates for SEB in immunoassays. We evaluated the affinity of a number of anti-SEB monoclonal antibodies (mAb) and an anti-SEB single domain antibody (sdAb) for SEB and its surrogates. One of the mAb's affinity was decreased by a factor of 3000 for the triple mutant, and another mAb's affinity for the triple mutant was decreased by 11-fold while the others bound the mutants nearly as well as they did the native toxin. MAGPIX sandwich immunoassays were used to evaluate the ability of all combinations of the recognition reagents to detect the SEB mutants in comparison to SEB and a chemically inactivated SEB. These results show that recombinant mutants of SEB can serve as much more useful surrogates for this hazardous material relative to the chemically inactivated toxin; however, even the point mutant impacted limits of detection, illustrating the need to evaluate the utility of toxin mutants on a case-by-case basis depending on the immunoreagents being employed.
机译:由于要处理危险材料,生物威胁剂检测方法的开发和测试就其性质而言非常复杂。通过热灭活或化学灭活制备的类毒素通常用于代替天然毒素。但是,排毒过程会降低药物在相似浓度下的检测能力。克服该局限性的一种方法是使用毒素突变体,其突变氨基酸序列足以消除或大大降低其毒性活性。尽管这种类毒素的制备方法受到更多控制,但仍不能保证所得产物的可检测性与天然毒素相同。在这项工作中,我们评估了两个重组表达的葡萄球菌肠毒素B(SEB)突变体,单点突变体(Y89A)和具有三个氨基酸改变的突变体(L45R,Y89A,Y94A)作为替代品的效用。免疫测定中的SEB。我们评估了许多抗SEB单克隆抗体(mAb)和抗SEB单结构域抗体(sdAb)对SEB及其替代物的亲和力。一个mAb对三重突变体的亲和力降低了3000倍,另一个mAb对三重突变体的亲和力降低了11倍,而其他mAb对突变体的结合几乎与天然毒素一样。与SEB和化学灭活的SEB相比,使用MAGPIX夹心免疫分析法评估识别试剂的所有组合检测SEB突变体的能力。这些结果表明,相对于化学灭活的毒素,SEB的重组突变体可以更有效地替代这种有害物质。但是,即使是点突变体也会影响检测极限,这说明需要根据所使用的免疫试剂,逐例评估毒素突变体的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号